| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1080/07853890600919911 |
| P698 | PubMed publication ID | 17008304 |
| P50 | author | Rosemary J Akhurst | Q91233041 |
| P2093 | author name string | Kelly A Harradine | |
| P2860 | cites work | Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB | Q22008707 |
| DRAGON, a bone morphogenetic protein co-receptor | Q24292739 | ||
| Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 | Q24296798 | ||
| Myostatin mutation associated with gross muscle hypertrophy in a child | Q24297666 | ||
| Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension | Q24298704 | ||
| Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils | Q24299279 | ||
| Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia | Q24302138 | ||
| Emilin1 links TGF-beta maturation to blood pressure homeostasis | Q24307505 | ||
| Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression | Q24316099 | ||
| A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva | Q24321505 | ||
| Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene | Q24533489 | ||
| Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II | Q24551154 | ||
| Marfan's syndrome | Q24553344 | ||
| Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1 | Q24651261 | ||
| Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment | Q24655306 | ||
| The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
| TGFbeta signaling in growth control, cancer, and heritable disorders | Q28142605 | ||
| ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development | Q28206311 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Making sense of latent TGFbeta activation | Q28217641 | ||
| A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 | Q28236792 | ||
| Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member | Q28237287 | ||
| Crystal structure of BMP-9 and functional interactions with pro-region and receptors | Q28246829 | ||
| Characterization of type I receptors for transforming growth factor-beta and activin | Q28251169 | ||
| Smads and early developmental signaling by the TGFbeta superfamily | Q28280601 | ||
| Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor | Q28510682 | ||
| Arteriovenous malformations in mice lacking activin receptor-like kinase-1 | Q28513355 | ||
| The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse | Q28590247 | ||
| Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability | Q28591995 | ||
| Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer | Q29616379 | ||
| Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome | Q29618845 | ||
| Functional characterization and genetic mapping of alk8. | Q31879070 | ||
| Primary pulmonary hypertension. A national prospective study | Q33169642 | ||
| Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? | Q33683412 | ||
| Nodal signalling in vertebrate development. | Q33833716 | ||
| Conserved left-right asymmetry of nodal expression and alterations in murine situs inversus. | Q34062451 | ||
| Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. | Q34085780 | ||
| A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). | Q34306976 | ||
| Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred | Q34325667 | ||
| Heterozygous TGFBR2 mutations in Marfan syndrome | Q34331334 | ||
| Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. | Q34381015 | ||
| A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle | Q34438337 | ||
| Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. | Q34510617 | ||
| Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. | Q34650188 | ||
| Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice | Q34661807 | ||
| Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases | Q35201617 | ||
| Ski and SnoN: negative regulators of TGF-beta signaling | Q35756034 | ||
| Transforming growth factor-beta1 to the bone | Q36131663 | ||
| Alterations in components of the TGF-beta superfamily signaling pathways in human cancer | Q36323395 | ||
| TGF beta inhibition for cancer therapy | Q36651746 | ||
| Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome | Q38317023 | ||
| Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors | Q39646992 | ||
| Nodal stability determines signaling range. | Q40471853 | ||
| Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein | Q40682198 | ||
| Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. | Q40920042 | ||
| Bone morphogenetic proteins in development | Q41100028 | ||
| TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies | Q44765711 | ||
| Mutations in the SMAD4/DPC4 gene in juvenile polyposis | Q45345229 | ||
| Association of the C-509-->T polymorphism, alone of in combination with the T869-->C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women | Q45877098 | ||
| Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis | Q46191709 | ||
| Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections | Q46606948 | ||
| Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development | Q46848207 | ||
| Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. | Q52192356 | ||
| Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. | Q52196601 | ||
| Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling. | Q52537703 | ||
| Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension | Q55670914 | ||
| Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension | Q57149199 | ||
| A Mutation Affecting the Latency-Associated Peptide of TGFβ1 in Camurati-Engelmann Disease Enhances Osteoclast Formationin Vitro | Q57849108 | ||
| Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease | Q57849197 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 403-414 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Mutations of TGFbeta signaling molecules in human disease | |
| P478 | volume | 38 |
| Q35125846 | Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo |
| Q38869875 | BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4. |
| Q24306137 | Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor |
| Q36588135 | Comparison of transforming growth factor beta expression in healthy and diseased human tendon |
| Q33614767 | Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients |
| Q36951674 | Extracellular control of TGFbeta signalling in vascular development and disease |
| Q36470683 | Gene modifiers in cystic fibrosis |
| Q51903618 | Identification of downstream targets of the bone morphogenetic protein pathway in the Drosophila nervous system. |
| Q43184280 | MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma |
| Q82521439 | Molecular Genetics of Colorectal Cancer |
| Q39398919 | Molecular mechanisms of intrauterine growth restriction |
| Q24323077 | Novel crosstalk to BMP signalling: cGMP-dependent kinase I modulates BMP receptor and Smad activity |
| Q27013037 | Novel sex-determining genes in fish and sex chromosome evolution |
| Q28914776 | Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2 |
| Q26769734 | Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role |
| Q24337871 | Protein associated with SMAD1 (PAWS1/FAM83G) is a substrate for type I bone morphogenetic protein receptors and modulates bone morphogenetic protein signalling |
| Q37971998 | Roles of TGFβ signaling Smads in squamous cell carcinoma |
| Q28594857 | Sertad1 encodes a novel transcriptional co-activator of SMAD1 in mouse embryonic hearts |
| Q36749575 | Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP) |
| Q37692270 | Spontaneous arterial dissection: phenotype and molecular pathogenesis |
| Q92635049 | Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors |
| Q91970844 | TGF-β Signaling Interferes With the Drosophila Innate Immune and Metabolic Response to Parasitic Nematode Infection |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
| Q35971562 | TGFβ and BMP Dependent Cell Fate Changes Due to Loss of Filamin B Produces Disc Degeneration and Progressive Vertebral Fusions |
| Q36462348 | Targeting the TGFβ signalling pathway in disease |
| Q34020080 | The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling |
| Q35065245 | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. |
| Q34507168 | The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression |
| Q36913146 | The transforming growth factor-beta superfamily in early spermatogenesis: potential relevance to testicular dysgenesis. |
| Q37387956 | The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors |
| Q41811073 | Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. |
| Q47070333 | Type IV collagens regulate BMP signalling in Drosophila |
| Q33703833 | USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling |
| Q55438202 | cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer |
Search more.